BRAF and colonic neoplasm: Interestingly, the BM1 colon cancer cells are more sensitive to the inhibition of BRAF, BCL2 and MEK compared to BM2; however, BM2 tumor cells are more sensitive to CDK1 inhibition, compared to BM1 [252].